Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Neuroendocrine Carcinomas of The Digestive System · Advanced Neuroendocrine Carcinomas Unknown Primary Origin

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brest University Hospital Centre, Brest, Brest, France
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Centre Régional de Lutte Contre le Cancer Institut Bergonié (Bordeaux), Bordeaux, Cedex, France
Contact: Study coordinator (A responsible person Selected by Sponsor) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Centre Oscar Lambret, Lille, Lille, France
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Hôpital Edouard Herriot (Hospices Civils Lyon), Lyon, Lyon, France
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Institut de Cancérologie de l'Ouest (Angers/Nantes), Nantes, Nantes, France
Contact: Study coordinator (A responsible person Selected by Sponsor) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Centre Hospitalier Universitaire de Toulouse, Toulouse, Toulouse, France
Contact: Study coordinator (A responsible person Selected by Sponsor) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Institut de Cancérologie de Lorraine (CLCC) Nancy, Vandœuvre-lès-Nancy, Vandœuvre-lès-Nancy Cedex, France
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Gustave Roussy, Villejuif, Villejuif,, France
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (A responsible person designed by sponsor, M.D.; Ph.D.)
Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
H.U Germans Trias i Pujols, Badalona, Barcelona, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
H.U. Vall d'Hebron, Barcelona, Barcelona, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D., Ph.D.)
Hospital Universitario de Burgos (HUBU), Burgos, Burgos, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
Hospital General Universitario Gregorio Marañón, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)
H.U Ramón y Cajal, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D., Ph.D.)
Hospital 12 de Octubre, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Designated by the Sponsor, M.D., Ph.D.)
H.U La Paz, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D., Ph.D.)
Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D., Ph.D.)
Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Contact: Principal Investigator (Principal investigator Selected by Sponsor, M.D.; Ph.D.)

Study leads

Jaume Capdevila, M.D., Ph.D.
Study Chair
Hospital Vall d'hebrón

View source on ClinicalTrials.gov